Claims Appeals banner - coverage Access support

Coverage & Access Support

The instructions below will help you get started. Click the "Forms & Resources" tab above to find more forms and information.

Logo for Injectafer(R) (ferric carboxymaltose injection)

Injectafer coverage access tabs

Billing and Coding

Code Description
Product package code
NDC 0517-0602-01 Injectafer (ferric carboxymaltose injection) 100 mg iron/2 mL single-use vial (individually boxed)
NDC 00517-0650-01 Injectafer (ferric carboxymaltose injection) 750 mg iron/15 mL single-use vial (individually boxed)
Product-specific billing code
HCPCS J1439 Injection, ferric carboxymaltose, 1 mg
Drug administration codes
CPT®* 96374


Therapeutic, prophylactic, or diagnostic injection (specify substance or drug) Intravenous push single or initial substance drug

Intravenous infusion for therapy, prophylaxis, or diagnosis (specify substance or drug); initial up to 1 hr
*CPT® codes, copyright 2020 American Medical Association (AMA). All rights reserved. CPT is a trademark of the AMA. No fee schedules, basic units, relative values, or related listings are included in the CPT. The AMA assumes no liability for the data contained herein. Applicable FARS/DFARS restrictions apply to government use.

Abbreviations: CPT, Current Procedural Terminology; FARS/DFARS, Federal Acquisition Regulation/Defense Federal Acquisition Regulation Supplement; HCPCS, Healthcare Common Procedure Coding System; NDC, National Drug Code.

We recommend verifying the coding policies for each individual health plan. Access Central Coordinators can provide information relating to payer-specific policies and can address other questions at 1-866-4-DSI-NOW.

Examples of IDA-related diagnosis codes

Injectafer claims forms require an appropriate ICD-10-CM code. The following table displays possible ICD-10-CM codes related to IDA.*

Primary diagnosis codes (ICD-10-CM)
D50.0 Iron deficiency anemia secondary to blood loss (chronic)
D50.1 Sideropenic dysphagia
D50.8 Other iron deficiency anemias
D50.9 Iron deficiency anemia, unspecified
D63.0 Anemia in neoplastic disease
CODE NEOPLASM FIRST (Confirm iron deficiency)
D63.1 Anemia in chronic kidney disease
CODE CKD STAGE FIRST (Confirm iron deficiency)
D63.8 Anemia in other chronic diseases
classified elsewhere CODE UNDERLYING DISEASE FIRST (Confirm iron deficiency)
D63.81 Antineoplastic chemotherapy-induced anemia (Confirm iron deficiency)

Other codes may be appropriate.

Coding for Injectafer is dependent on the insurer and the care setting in which the drug will be administered. These tables are provided for informational purposes only, and you have the responsibility to ensure that claims and codes submitted are accurate, complete, and applicable. Healthcare providers need to make coding decisions based on the diagnosis and treatment of each patient and the specific insurer. Please visit or other payers’ websites to obtain additional guidance on their processes.

A code specific for your IDA patient’s underlying condition

The following table displays possible secondary ICD-10-CM codes that may be appropriate for patients prescribed Injectafer.*

Codes related to IDA patient’s underlying condition (ICD-10-CM)
K50.0-K50.919 Crohn's disease [regional enteritis]
K51.0-K51.919 Ulcerative colitis
K90.0 Celiac disease
K90.4 Malabsorption due to intolerance not elsewhere classified
K90.9 Intestinal malabsorption unspecified
N18.1 Chronic kidney disease, stage 1
N18.2 Chronic kidney disease, stage 2
N18.30 Chronic kidney disease stage 3 unspecified
N18.31 Chronic kidney disease stage 3a
N18.32 Chronic kidney disease stage 3b
N18.4 Chronic kidney disease, stage 4
N18.5 Chronic kidney disease, stage 5
N18.6 End-stage renal disease
N18.9 Chronic kidney disease, unspecified
N92.0 Excessive and frequent menstruation with regular cycle
N92.5 Other specified irregular menstruation
N92.6 Irregular menstruation, unspecified
T45.4X5A Adverse effect of iron and its compounds, initial encounter
T50.905A Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter

*A joint effort between the healthcare provider and the coder is essential to achieve complete and accurate documentation, code assignment, and reporting of diagnoses and procedures. This information is provided to assist both the healthcare provider and the coder in identifying potential diagnoses. The importance of consistent, complete documentation in the medical record cannot be overemphasized. Without such documentation, accurate coding cannot be achieved. The entire record should be reviewed to determine the specific reason for the encounter and the conditions treated.

Secondary code suggestions only; appropriate codes not limited to those listed above. Injectafer is indicated to treat IDA; it is not indicated to treat the above listed underlying conditions. Some listed diagnosis codes may indicate a subcategory and be nonbillable. For reporting purposes, only codes with the full number of required characters are permissible.

Abbreviation: ICD-10-CM, International Classification of Diseases, Tenth Revision, Clinical Modification.

We recommend verifying the coding policies for each individual health plan. Reimbursement specialists can provide information relating to payer-specific policies and can address other questions at 1-866-4-DSI-NOW.

The completion and submission of coverage- or reimbursement-related documentation are the responsibility of the patient and healthcare provider. Daiichi Sankyo, Inc., makes no representation or guarantee concerning coverage or reimbursement for any service or item. A completed form includes signatures from both the physician and the patient. Before submitting, please ensure all required information is provided.